GF
SLXNW

Gabelli Funds’s Silexion Therapeutics Corp Warrant SLXNW Stock Holding History

Gabelli Funds’s Portfolio SLXNW Stock Details SLXNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$1.25K Hold
30,496
– – ﹤0.01% 1218
2025
Q1 		$2.33K Buy
+30,496
New +$2.33K ﹤0.01% 1083
2024
Q4 		– Sell
-30,496
Closed -$967 – 1115
2024
Q3 		$967 Buy
+30,496
New +$967 ﹤0.01% 1091